GSK3B and Alzheimer disease: In a double transgenic AD model in mice, it was demonstrated that the inhibition of GSK3β signaling regulates BACE1 expression and that this is dependent on NF-κB; as a result, there was reduced Aβ and neuritic plaque formation, as well as reversed memory deficits.